{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:26:08Z","timestamp":1740108368648,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Evidence regarding the best antibiotic regimen and the route of administration to treat acute focal bacterial nephritis (AFBN) is scarce. The aim of the present study was to compare the effectiveness of intravenous (IV) \u03b2-lactam antibiotics versus oral quinolones.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective single centre study of patients diagnosed with AFBN between January 2017 and December 2018 in Hospital Universitari Vall d\u2019Hebron, Barcelona (Spain). Patients were identified from the diagnostic codifications database. Patients treated with oral quinolones were compared with those treated with IV \u03b2-lactam antibiotics. Therapeutic failure was defined as death, relapse, or evolution to abscess within the first 30 days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 264 patients fulfilled the inclusion criteria. Of those, 103 patients (39%) received oral ciprofloxacin, and 70 (26.5%) IV \u03b2-lactam. The most common isolated microorganism was <jats:italic>Escherichia coli<\/jats:italic> (149, 73.8%) followed by <jats:italic>Klebsiella pneumoniae<\/jats:italic> (26, 12.9%). Mean duration of treatment was 21.3 days (SD 7.9). There were no statistical differences regarding therapeutic failure between oral quinolones and IV \u03b2-lactam treatment (6.6% vs. 8.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.6). Out of the 66 patients treated with intravenous antibiotics, 4 (6.1%) experienced an episode of phlebitis and 1 patient (1.5%) an episode of catheter-related bacteraemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>When susceptible, treatment of AFBN with oral quinolones is as effective as IV \u03b2-lactam treatment with fewer adverse events.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10096-024-04871-2","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T05:01:54Z","timestamp":1717995714000},"page":"1559-1567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral quinolones versus intravenous \u03b2-lactam for the treatment of acute focal bacterial nephritis: a retrospective cohort study"],"prefix":"10.1007","volume":"43","author":[{"given":"L.","family":"Aceituno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nu\u00f1ez-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Serra-Pladevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Vi\u00f1ado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Castella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-3090","authenticated-orcid":false,"given":"Laura","family":"Escol\u00e0-Verg\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pigrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Falc\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"y O.","family":"Len","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"4871_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1148\/132.3.553","volume":"132","author":"AT Rosenfield","year":"1979","unstructured":"Rosenfield AT, Glickman MG, Taylor KJ et al (1979) Acute focal bacterial nephritis (acute lobar nephronia). Radiology 132:553","journal-title":"Radiology"},{"issue":"1","key":"4871_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-10809-5","volume":"12","author":"S Jiao","year":"2022","unstructured":"Jiao S, Yan Z, Zhang C, Li J, Zhu J (2022) Clinical features of acute focal bacterial nephritis in adults. Sci Rep 12(1):1\u20135. https:\/\/doi.org\/10.1038\/s41598-022-10809-5","journal-title":"Sci Rep"},{"key":"4871_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medcli.2010.02.042","volume":"136","author":"J Palou","year":"2011","unstructured":"Palou J, Pigrau C, Molina I, Ledesma JM, Angulo J (2011) Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC study): implications on empiric therapy. Med Clin (Barc) 136:1\u20137","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"4871_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMcp1702758","volume":"378","author":"JR Johnson","year":"2018","unstructured":"Johnson JR, Russo TA (2018) Acute pyelonephritis in adults. N Engl J Med 378(1):48\u201359","journal-title":"N Engl J Med"},{"issue":"6","key":"4871_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/crad.2002.0935","volume":"57","author":"KD Farmer","year":"2002","unstructured":"Farmer KD, Gellett LR, Dubbins PA (2002) The sonographic appearance of acute focal pyelonephritis 8 years experience. Clin Radiol 57(6):483\u2013487","journal-title":"Clin Radiol"},{"issue":"5","key":"4871_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.eimc.2016.11.005","volume":"35","author":"M de Cueto","year":"2017","unstructured":"de Cueto M, Aliaga L, Al\u00f3s JI et al (2017) Resumen ejecutivo del diagn\u00f3stico y tratamiento de las infecciones del tracto urinario. Gu\u00eda De La Sociedad Espa\u00f1ola De Enfermedades Infecciosas Y Microbiolog\u00eda Cl\u00ednica (SEIMC). Enferm Infecc Microbiol Clin 35(5):314\u2013320. https:\/\/doi.org\/10.1016\/j.eimc.2016.11.005","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"12","key":"4871_CR7","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1111\/jan.14565","volume":"76","author":"N Marsh","year":"2020","unstructured":"Marsh N, Webster J, Ullman AJ, Mihala G, Cooke M, Chopra V et al (2020) Peripheral intravenous catheter non-infectious complications in adults: a systematic review and meta-analysis. J Adv Nurs 76(12):3346\u20133362","journal-title":"J Adv Nurs"},{"key":"4871_CR8","unstructured":"Giraldi G, Montesano M, Sandorfi F, Iachini M, Orsi GB (2019) Excess length of hospital stay due to healthcare acquired infections: methodologies evaluation. ;507\u2013516"},{"issue":"11","key":"4871_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/archsurg.133.11.1221","volume":"133","author":"DJ Hackam","year":"1998","unstructured":"Hackam DJ, Christou N, Khaliq Y, Duffy DR, Vaughan D, Marshall JC et al (1998) Bioavailability of oral ciprofloxacin in early postsurgical patients. Arch Surg 133(11):1221\u20131225","journal-title":"Arch Surg"},{"issue":"9840","key":"4871_CR10","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","volume":"380","author":"T Sandberg","year":"2012","unstructured":"Sandberg T, Skoog G, Hermansson AB et al (2012) Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 380(9840):484\u2013490. https:\/\/doi.org\/10.1016\/S0140-6736(12)60608-4","journal-title":"Lancet"},{"issue":"4","key":"4871_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10140-020-01771-8","volume":"27","author":"T Hosokawa","year":"2020","unstructured":"Hosokawa T, Tanami Y, Sato Y, Oguma E (2020) Comparison of imaging findings between acute focal bacterial nephritis (acute lobar nephronia) and acute pyelonephritis: a preliminary evaluation of the sufficiency of ultrasound for the diagnosis of acute focal bacterial nephritis. Emerg Radiol 27(4):405\u2013412","journal-title":"Emerg Radiol"},{"key":"4871_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejim.2016.12.002","volume":"39","author":"J Campos-Franco","year":"2017","unstructured":"Campos-Franco J, Macia C, Huelga E, Diaz-Louzao C, Gude F, Alende R, Gonzalez-Quintela A (2017) Acute focal bacterial nephritis in a cohort of hospitalized adult patients with acute pyelonephritis. Assessment of risk factors and a predictive model. Eur J Intern Med 39:69\u201374 Epub 2016 Dec 13. PMID: 27986362","journal-title":"Eur J Intern Med"},{"issue":"2","key":"4871_CR13","first-page":"145","volume":"32","author":"R Cant\u00f3n","year":"2019","unstructured":"Cant\u00f3n R, Loza E, Aznar J, Castillo FJ, Cercenado E, Fraile-Ribot PA, Gonz\u00e1lez-Romo F, L\u00f3pez-Hontangas JL, Rodr\u00edguez-Lozano J, Su\u00e1rez-Barrenechea AI, Tubau F, D\u00edaz-Rega\u00f1\u00f3n J, L\u00f3pez-Mendoza D, SMART-Spain Working Group (2019) Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017). Rev Esp Quimioter 32(2):145\u2013155 Epub 2019 Feb 13. PMID: 30761824; PMCID: PMC6441989","journal-title":"Rev Esp Quimioter"},{"issue":"12","key":"4871_CR14","doi-asserted-by":"publisher","first-page":"e0220265","DOI":"10.1371\/journal.pone.0220265","volume":"14","author":"IA Critchley","year":"2019","unstructured":"Critchley IA, Cotroneo N, Pucci MJ, Mendes R (2019) The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS ONE 14(12):e0220265. https:\/\/doi.org\/10.1371\/journal.pone.0220265PMID: 31821338; PMCID: PMC6903708","journal-title":"PLoS ONE"},{"issue":"4","key":"4871_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0016-5085(96)70069-0","volume":"111","author":"M Navasa","year":"1996","unstructured":"Navasa M, Follo A, Llovet JM et al (1996) Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 111(4):1011\u20131017. https:\/\/doi.org\/10.1016\/S0016-5085(96)70069-0","journal-title":"Gastroenterology"},{"key":"4871_CR16","first-page":"1426","volume":"50","author":"I Tuncer","year":"2003","unstructured":"Tuncer I, Topeu N, Durmus A et al (2003) Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis. Hepatogastroenterology 50:1426\u20131430","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"4871_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2036.2006.02706.x","volume":"23","author":"P Angeli","year":"2006","unstructured":"Angeli P, Guarda S, Fasolato S et al (2006) Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther 23(1):75\u201384. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02706.x","journal-title":"Aliment Pharmacol Ther"},{"key":"4871_CR18","doi-asserted-by":"publisher","first-page":"205435811988431","DOI":"10.1177\/2054358119884310","volume":"6","author":"A Guella","year":"2019","unstructured":"Guella A, Khan A, Jarrah D (2019) Acute Focal Bacterial Nephritis: two cases and review of the literature. Can J Kidney Health Dis 6:2054358119884310. https:\/\/doi.org\/10.1177\/2054358119884310PMID: 31695922; PMCID: PMC6820168","journal-title":"Can J Kidney Health Dis"},{"key":"4871_CR19","doi-asserted-by":"crossref","unstructured":"Bosch-Nicolau P, Falc\u00f3 V, Vi\u00f1ado B, Andreu A, Len O, Almirante B et al (2017) A cohort study of risk factors that influence empirical treatment of patients with acute pyelonephritis. Antimicrob Agents Chemother. ;61(12)","DOI":"10.1128\/AAC.01317-17"},{"key":"4871_CR20","doi-asserted-by":"crossref","unstructured":"Naucl\u00e9r P, Huttner A, van Werkhoven CH, Singer M, Tattevin P, Einav S, T\u00e4ngd\u00e9n T (2021) Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect. ;27(2):175\u2013181. doi: 10.1016\/j.cmi.2020.02.032. Epub 2020 Feb 29. PMID: 32120032","DOI":"10.1016\/j.cmi.2020.02.032"},{"key":"4871_CR21","doi-asserted-by":"publisher","first-page":"204993612311796","DOI":"10.1177\/20499361231179668","volume":"10","author":"KN Billmeyer","year":"2023","unstructured":"Billmeyer KN, Ross JK, Hirsch EB, Evans MD, Kline SE, Galdys AL (2023) Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort. Ther Adv Infect Dis 10:20499361231179668. https:\/\/doi.org\/10.1177\/20499361231179668PMID: 37332294; PMCID: PMC10272639","journal-title":"Ther Adv Infect Dis"},{"issue":"5","key":"4871_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1001825","volume":"12","author":"HK Li","year":"2015","unstructured":"Li HK, Agweyu A, English M, Bejon P (2015) An unsupported preference for intravenous antibiotics. PLoS Med 12(5):1\u20138. https:\/\/doi.org\/10.1371\/journal.pmed.1001825","journal-title":"PLoS Med"},{"issue":"4","key":"4871_CR23","doi-asserted-by":"publisher","first-page":"ofae193","DOI":"10.1093\/ofid\/ofae193","volume":"11","author":"JJ Veillette","year":"2024","unstructured":"Veillette JJ, May SS, Alzaidi S, Olson J, Butler AM, Waters CD, Jackson K, Hutton MA, Webb BJ (2024) Real-world effectiveness of intravenous and oral antibiotic stepdown strategies for Gram-negative complicated urinary tract infection with bacteremia. Open Forum Infect Dis 11(4):ofae193. https:\/\/doi.org\/10.1093\/ofid\/ofae193PMID: 38665174; PMCID: PMC11045028","journal-title":"Open Forum Infect Dis"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04871-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04871-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04871-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T07:04:38Z","timestamp":1721459078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04871-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["4871"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04871-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"20 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}